Hereby I declare that the views expressed in my posts are those of Alp Bugra Basat and do not necessarily reflect the views of my industry partners, research supervisors-collaborators and companies I have invested in. I like basic science; if it is translated into new treatments. I like the biotechs with cutting-edge science. I don't like PI3K, ras, akt inhibitors. I like antibody-drug conjugates. I like sirtuin. I may not believe in β-amyloid. I really like ivacaftor. I am crazy about talimogene laherparepvec. I love the drugs like eteplirsen. In addition, I don't fall in love with stocks, it means that my opinions expressed here can change in a milisecond, after I get more info. A special thank goes to Osman Murat Bastopcu!
I'm a radiologist by trade, but the goal is to leverage that medical knowledge as a competitive advantage in the markets. I aim to include all of the following in my analyses to ensure high quality: 1) quantitative estimates; 2) new information or inferences that are not already disseminated throughout the market; and 3) hypotheses that are testable, i.e. can be proved right or wrong. I have a serious allergy to question marks and will never, ever include one in an article title.
My dream is to co-found a biotech and bring a cure from the lab to the bedside. In the meantime, saving lives in clinical practice is a perfectly acceptable alternative.
Please note that all opinions I express on this website reflect my personal beliefs only and are completely independent of my current or past employers and/or affiliated institutions.
Microcap Monster is focused on small-cap and micro-cap trading with a specific interest in finding the latest penny stock or OTC scams and either alerting the public to our findings or using the findings to short the stocks we research, or both. Although we identify potential research targets in many ways, much of our work involves tracking reverse mergers with an intent to profit from market manipulations commonly associated with these stocks.